About: http://webisa.webdatacommons.org/430320228

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	YM Biosciences owns 80 percent of CIMYM, the company that has the rights to develop nimotuzumab in North America, Europe, Japan and other places.
http://www.w3.org/ns/prov#wasQuotedFrom	phys.org